These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2906649)

  • 21. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 22. Engineering neurons for Parkinson's disease.
    Lindvall O
    Nat Biotechnol; 1999 Jul; 17(7):635-6. PubMed ID: 10409349
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neurotoxin candidates as pathogenic agents of Parkinson's disease].
    Naoi M
    No To Shinkei; 1997 Sep; 49(9):793-803. PubMed ID: 9310995
    [No Abstract]   [Full Text] [Related]  

  • 24. Nitration of soluble proteins in organotypic culture models of Parkinson's disease.
    Larsen TR; Söderling AS; Caidahl K; Roepstorff P; Gramsbergen JB
    Neurochem Int; 2008 Feb; 52(3):487-94. PubMed ID: 17900761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Da-Bu-Yin-Wan and Qian-Zheng-San, two traditional Chinese herbal formulas, up-regulate the expression of mitochondrial subunit NADH dehydrogenase 1 synergistically in the mice model of Parkinson's disease.
    Zhang Y; Sun HM; He X; Wang YY; Gao YS; Wu HX; Xu H; Gong XG; Guo ZY
    J Ethnopharmacol; 2013 Mar; 146(1):363-71. PubMed ID: 23347961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication.
    Orimo S; Uchihara T; Nakamura A; Mori F; Ikeuchi T; Onodera O; Nishizawa M; Ishikawa A; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2008 Nov; 116(5):575-7. PubMed ID: 18751989
    [No Abstract]   [Full Text] [Related]  

  • 27. Structure and neurotoxicity of novel amyloids derived from the BRI gene.
    Gibson G; El-Agnaf OM; Anwar Z; Sidera C; Isbister A; Austen BM
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1111-2. PubMed ID: 16246057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.
    Huisman E; Uylings HB; Hoogland PV
    Mov Disord; 2008 Jul; 23(10):1407-13. PubMed ID: 18581481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.
    Scholz J; Toska K; Luborzewski A; Maass A; Schünemann V; Haavik J; Moser A
    FEBS J; 2008 May; 275(9):2109-21. PubMed ID: 18355318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats].
    Wang S; Qi XJ; Han D
    Zhongguo Zhen Jiu; 2009 May; 29(5):391-4. PubMed ID: 19489498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson's disease.
    García MC; Cinquina V; Palomo-Garo C; Rábano A; Fernández-Ruiz J
    Neurosci Lett; 2015 Feb; 587():1-4. PubMed ID: 25481767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.
    McRitchie DA; Cartwright HR; Halliday GM
    Exp Neurol; 1997 Mar; 144(1):202-13. PubMed ID: 9126172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures.
    Carvey PM; Ptak LR; Nath ST; Sierens DK; Mufson EJ; Goetz CG; Klawans HL
    Exp Neurol; 1993 Mar; 120(1):149-52. PubMed ID: 8097475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylglyoxal increases dopamine level and leads to oxidative stress in SH-SY5Y cells.
    Xie B; Lin F; Peng L; Ullah K; Wu H; Qing H; Deng Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):950-6. PubMed ID: 25274329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical aspects of Parkinson's disease.
    Nagatsu T
    Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
    [No Abstract]   [Full Text] [Related]  

  • 37. Oxidative stress to dopaminergic neurons as models of Parkinson's disease.
    Gille G; Hung ST; Reichmann H; Rausch WD
    Ann N Y Acad Sci; 2004 Jun; 1018():533-40. PubMed ID: 15240412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-neurotoxins of Naja atra and Naja kaouthia snakes in different regions.
    Wei JF; Lü QM; Jin Y; Li DS; Xiong YL; Wang WY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Aug; 35(8):683-8. PubMed ID: 12897961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
    Bordet R; Broly F; Destée A; Libersa C
    Adv Neurol; 1996; 69():97-100. PubMed ID: 8615190
    [No Abstract]   [Full Text] [Related]  

  • 40. Mental disturbances in Parkinson's disease and related disorders: the role of excitotoxins.
    Obál I; Majláth Z; Toldi J; Vécsei L
    J Parkinsons Dis; 2014; 4(2):139-50. PubMed ID: 24346238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.